Skip to main content
. 2022 Jun 23;127(6):1153–1161. doi: 10.1038/s41416-022-01892-6

Fig. 3. 27-plex human cytokine array of patients who received RGF versus VOR/HCQ.

Fig. 3

Assay done at Cycle 1 day 1 (C1D1, baseline) and Cycle 1 day 15 (C1D15). Low = 1–3 cycles, High = 4+ cycles completed. *P < 0.05, ~10% increase TNFa after treatment. VOR   vorinostat, HCQ   hydroxychloroquine, RGF   regorafenib.